Identifying somatic mutations in cell‐free DNA of aggressive lymphoma patients: First cell‐free DNA results from the molecular profiling for lymphoma (MaPLe) study von Lopez Pascua, L.D., Ahmed, S.M., Barrans, S., Burton, C., Clipson, A.J., Cucco, F., Cutts, A., Dreau, H., Du, M., Joke, D., Mizani, R.T., Salminen, O., Van Hoppe, M., Vaughan‐Spickers, N., Schuh, A., Johnson, P.W.

Volltext

KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype von Clipson, A, Wang, M, de Leval, L, Ashton-Key, M, Wotherspoon, A, Vassiliou, G, Bolli, N, Grove, C, Moody, S, Escudero-Ibarz, L, Gundem, G, Brugger, K, Xue, X, Mi, E, Bench, A, Scott, M, Liu, H, Follows, G, Robles, E F, Martinez-Climent, J A, Oscier, D, Watkins, A J, Du, M-Q

Volltext

PROGNOSTIC SIGNIFICANCE AND CORRELATION TO GENE EXPRESSION PROFILE OF EZH2 MUTATIONS IN DIFFUSE LARGE B‐CELL LYMPHOMA (DLBL) IN 2 LARGE PROSPECTIVE STUDIES von Cummin, T.E., Araf, S., Du, M., Barrans, S., Bentley, M.A., Clipson, A., Wang, M., Ahmed, S., Rahim, T., Shah, C., Hamid, D., Dhondt, J., Maishman, T., Vaughan‐Spickers, N., Pocock, C., Forbes, A., O'Callaghan, A., Westhead, D., Griffiths, G.O., Fitzgibbon, J., Tooze, R.M., Care, M.A., Burton, C.H., Davies, A.J., Johnson, P.W.

Volltext

DIFFERENTIAL EFFICACY OF BORTEZOMIB IN SUBTYPES OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBL): a PROSPECTIVE RANDOMISED STUDY STRATIFIED BY TRANSCRIPTOME PROFILING: REMODL‐B von Davies, A.J., Barrans, S., Maishman, T., Cummin, T.E., Bentley, M., Mamot, C., Novak, U., Caddy, J., Hamid, D., Kazmi‐Stokes, S.H., Mcmillan, A., Fields, P.A., Pocock, C., Kruger, A., Collins, G., Sha, C., Clipson, A., Wang, M., Tooze, R.M., Care, M.A., Griffiths, G.O., Du, M., Westhead, D.R., Burton, C., Jack, A., Johnson, P.W.

Volltext